Recent Quotes

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-06-16
REV		(EXPECTED)2021-06-16

Q4 2020		Est.		Actual		Surprise
EPS		-0.570		-0.520		0.0500
REV				180.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BYSI	BeyondSpring	11.63	0.20	1.75%		454.8M

BeyondSpring Frequently Asked Questions

How do I buy BeyondSpring (BYSI) stock?

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Who are BeyondSpring's (BYSI) competitors?

Other companies in BeyondSpring’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX), 89bio (NASDAQ:ETNB) and Inozyme Pharma (NASDAQ:INZY).

What is the target price for BeyondSpring (BYSI) stock?

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by HC Wainwright & Co. on April 5, 2021. The analyst firm set a price target for 0.00 expecting BYSI to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for BeyondSpring (BYSI)?

The stock price for BeyondSpring (NASDAQ: BYSI) is $11.63 last updated Mon Jun 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does BeyondSpring (BYSI) pay a dividend?

There are no upcoming dividends for BeyondSpring.

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

BeyondSpring’s Q2 earnings are confirmed for after-market on September 2, 2021.

Is BeyondSpring (BYSI) going to split?

There is no upcoming split for BeyondSpring.

What sector and industry does BeyondSpring (BYSI) operate in?

BeyondSpring is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.